401 related articles for article (PubMed ID: 35928032)
1. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
[TBL] [Abstract][Full Text] [Related]
2. Automated and reusable deep learning (AutoRDL) framework for predicting response to neoadjuvant chemotherapy and axillary lymph node metastasis in breast cancer using ultrasound images: a retrospective, multicentre study.
You J; Huang Y; Ouyang L; Zhang X; Chen P; Wu X; Jin Z; Shen H; Zhang L; Chen Q; Pei S; Zhang B; Zhang S
EClinicalMedicine; 2024 Mar; 69():102499. PubMed ID: 38440400
[TBL] [Abstract][Full Text] [Related]
3. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study.
Huang Y; Zhu T; Zhang X; Li W; Zheng X; Cheng M; Ji F; Zhang L; Yang C; Wu Z; Ye G; Lin Y; Wang K
EClinicalMedicine; 2023 Apr; 58():101899. PubMed ID: 37007742
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
Sui L; Yan Y; Jiang T; Ou D; Chen C; Lai M; Ni C; Zhu X; Wang L; Yang C; Li W; Yao J; Xu D
Breast Cancer Res Treat; 2023 Nov; 202(1):45-55. PubMed ID: 37639063
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
Wu S; Hong G; Xu A; Zeng H; Chen X; Wang Y; Luo Y; Wu P; Liu C; Jiang N; Dang Q; Yang C; Liu B; Shen R; Chen Z; Liao C; Lin Z; Wang J; Lin T
Lancet Oncol; 2023 Apr; 24(4):360-370. PubMed ID: 36893772
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract][Full Text] [Related]
8. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract][Full Text] [Related]
9. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
10. Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study.
He J; Wang B; Tao J; Liu Q; Peng M; Xiong S; Li J; Cheng B; Li C; Jiang S; Qiu X; Yang Y; Ye Z; Zeng F; Zhang J; Liu D; Li W; Chen Z; Zeng Q; Fan JB; Liang W
Lancet Digit Health; 2023 Oct; 5(10):e647-e656. PubMed ID: 37567793
[TBL] [Abstract][Full Text] [Related]
11. An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study.
Wu L; Ye W; Liu Y; Chen D; Wang Y; Cui Y; Li Z; Li P; Li Z; Liu Z; Liu M; Liang C; Yang X; Xie Y; Wang Y
Breast Cancer Res; 2022 Nov; 24(1):81. PubMed ID: 36414984
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
13. Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.
She Y; He B; Wang F; Zhong Y; Wang T; Liu Z; Yang M; Yu B; Deng J; Sun X; Wu C; Hou L; Zhu Y; Yang Y; Hu H; Dong D; Chen C; Tian J
EBioMedicine; 2022 Dec; 86():104364. PubMed ID: 36395737
[TBL] [Abstract][Full Text] [Related]
14. Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study.
Zhou S; Sun D; Mao W; Liu Y; Cen W; Ye L; Liang F; Xu J; Shi H; Ji Y; Wang L; Chang W
EClinicalMedicine; 2023 Nov; 65():102271. PubMed ID: 37869523
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort study.
Liao J; Gui Y; Li Z; Deng Z; Han X; Tian H; Cai L; Liu X; Tang C; Liu J; Wei Y; Hu L; Niu F; Liu J; Yang X; Li S; Cui X; Wu X; Chen Q; Wan A; Jiang J; Zhang Y; Luo X; Wang P; Cai Z; Chen L
EClinicalMedicine; 2023 Jun; 60():102001. PubMed ID: 37251632
[TBL] [Abstract][Full Text] [Related]
17. Nomogram based on quantitative dynamic contrast-enhanced magnetic resonance imaging, apparent diffusion coefficient, and clinicopathological features for early prediction of pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy.
He M; Su J; Ruan H; Song Y; Ma M; Xue F
Quant Imaging Med Surg; 2023 Jul; 13(7):4089-4102. PubMed ID: 37456283
[TBL] [Abstract][Full Text] [Related]
18. Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer.
Xiao Y; Ding J; Ma D; Chen S; Li X; Yu K
Front Immunol; 2022; 13():877825. PubMed ID: 35663978
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
EBioMedicine; 2024 May; 104():105152. PubMed ID: 38728838
[TBL] [Abstract][Full Text] [Related]
20. Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study.
Yuan L; Yang L; Zhang S; Xu Z; Qin J; Shi Y; Yu P; Wang Y; Bao Z; Xia Y; Sun J; He W; Chen T; Chen X; Hu C; Zhang Y; Dong C; Zhao P; Wang Y; Jiang N; Lv B; Xue Y; Jiao B; Gao H; Chai K; Li J; Wang H; Wang X; Guan X; Liu X; Zhao G; Zheng Z; Yan J; Yu H; Chen L; Ye Z; You H; Bao Y; Cheng X; Zhao P; Wang L; Zeng W; Tian Y; Chen M; You Y; Yuan G; Ruan H; Gao X; Xu J; Xu H; Du L; Zhang S; Fu H; Cheng X
EClinicalMedicine; 2023 Mar; 57():101834. PubMed ID: 36825238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]